Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy

Protein Cell. 2019 Nov;10(11):840-845. doi: 10.1007/s13238-019-0642-z.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Animals
  • B7 Antigens* / antagonists & inhibitors
  • B7 Antigens* / metabolism
  • CTLA-4 Antigen* / antagonists & inhibitors
  • CTLA-4 Antigen* / metabolism
  • Carcinoma, Renal Cell* / drug therapy
  • Carcinoma, Renal Cell* / immunology
  • Carcinoma, Renal Cell* / metabolism
  • Female
  • Humans
  • Kidney Neoplasms* / drug therapy
  • Kidney Neoplasms* / immunology
  • Kidney Neoplasms* / metabolism
  • Male
  • Mice, Inbred BALB C
  • Middle Aged
  • Programmed Cell Death 1 Receptor* / antagonists & inhibitors
  • Programmed Cell Death 1 Receptor* / metabolism

Substances

  • B7 Antigens
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • VSIR protein, human